Nektar Therapeutics (NKTR) Q4 2025 Earnings

6NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-3.6
-2.39
-1.18
0.03

Details

Expected EPS
-2.684875
Actual EPS
-1.87
Surprise EPS
0.81
Surprise Percent
+30.35%

Description

Nektar Therapeutics (NKTR) has reported earnings of -1.87 per share for Q4 2025.

0 Comments

Share your thoughts